login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
DISC MEDICINE INC (IRON) Stock News
USA
- NASDAQ:IRON -
US2546041011
-
Common Stock
83.795
USD
-3.2 (-3.68%)
Last: 11/7/2025, 12:22:17 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IRON Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: Chartmill
Disc Medicine Inc (NASDAQ:IRON) Reports Wider-Than-Expected Q3 2025 Loss Amid Pipeline Advancements
a day ago - By: Disc Medicine Inc
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
a day ago - By: Disc Medicine Inc
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
4 days ago - By: Disc Medicine Inc
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
7 days ago - By: Disc Medicine Inc
Disc Medicine to Participate in Upcoming Investor Conferences
7 days ago - By: Disc Medicine Inc
Disc Medicine to Participate in Upcoming Investor Conferences
18 days ago - By: Disc Medicine Inc
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
18 days ago - By: Disc Medicine Inc
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
18 days ago - By: Disc Medicine Inc
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
18 days ago - By: Disc Medicine Inc
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
18 days ago - By: Disc Medicine Inc
Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones
18 days ago - By: Disc Medicine Inc
Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones
21 days ago - By: Benzinga
- Mentions:
SLI
SLB
OMER
WTO
...
Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings
21 days ago - By: Benzinga
- Mentions:
SIFY
AXP
OMI
LBRT
...
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday
21 days ago - By: Investor's Business Daily
- Mentions:
RY
RY.CA
RVMD
ACHV
...
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly.
21 days ago - By: Disc Medicine Inc
Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
21 days ago - By: Disc Medicine Inc
Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
22 days ago - By: Stocktwits
- Mentions:
RVMD
REGN
SNY
LLY
...
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program
22 days ago - By: Disc Medicine Inc
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
22 days ago - By: Disc Medicine Inc
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
a month ago - By: Disc Medicine Inc
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
a month ago - By: Disc Medicine Inc
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
2 months ago - By: Disc Medicine Inc
Disc Medicine to Participate in Upcoming Investor Conferences
2 months ago - By: Shattuck Labs, Inc.
- Mentions:
STTK
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
3 months ago - By: The Motley Fool
Disc Medicine (IRON) Q2 Loss Widens 109%
3 months ago - By: Disc Medicine Inc
Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update
3 months ago - By: Disc Medicine Inc
Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Disc Medicine Inc
Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025
4 months ago - By: Disc Medicine Inc
Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025
4 months ago - By: Disc Medicine Inc
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
4 months ago - By: Disc Medicine Inc
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
Please enable JavaScript to continue using this application.